Evaluation and management of galactorrhea

Area of Science:

• Endocrinology
• Reproductive Medicine

Background:

• Galactorrhea, or abnormal milk production, is frequently linked to hyperprolactinemia.
• Hyperprolactinemia often results from medications, pituitary adenomas, or other sellar/suprasellar lesions.
• Less common causes include hypothyroidism, renal insufficiency, pregnancy, and nipple stimulation.

Purpose of the Study:

• To outline the diagnostic evaluation and management of galactorrhea.
• To identify the common and less common causes of galactorrhea.
• To describe treatment strategies for hyperprolactinemia-induced galactorrhea.

Main Methods:

• Assess patients with galactorrhea by measuring prolactin levels after ruling out pathologic nipple discharge.
• For hyperprolactinemic patients, rule out pregnancy and assess thyroid and renal function.
• Consider brain MRI if no other cause for hyperprolactinemia is identified.

Main Results:

• Hyperprolactinemia is a primary driver of galactorrhea, particularly when associated with amenorrhea.
• Medication-induced hyperprolactinemia and pituitary adenomas are frequent etiologies.
• Dopamine agonists are the mainstay treatment for prolactinomas, while medication adjustment or discontinuation is key for drug-induced cases.

Conclusions:

• Diagnostic workup for galactorrhea should prioritize prolactin level measurement.
• Management strategies vary based on the cause of hyperprolactinemia, with dopamine agonists being effective for prolactinomas and bothersome idiopathic galactorrhea.
• Normoprolactinemic, non-bothersome galactorrhea requires reassurance without specific treatment.